EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Mass Spectrometry Advancements and Applications for Biomarker Discovery, Diagnostic Innovations, and Personalized Medicine

Ahrum Son iD, Woojin Kim iD, Jongham Park iD, Yongho Park, Wonseok Lee, Sangwoon Lee, Hyunsoo Kim iD

International Journal of Molecular Sciences · 12.09.2024 · 25 (18) · 9880

DOI: 10.3390/ijms25189880 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 12.09.2024. Verfasst von Ahrum Son und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Medicine, Scripps Research, San Diego, CA 92037, USA. Hauptthemen laut MEDLINE: Precision Medicine, Biomarkers, Mass Spectrometry. Die Arbeit wurde bisher 84-mal zitiert (Crossref) und nennt 112 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea (NRF), Korea Basic Science Institute (National research Facilities and Equipment Center), by Institute of Information & communications Technology Planning & Evaluation (IITP).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mass spectrometry (MS) has revolutionized clinical chemistry, offering unparalleled capabilities for biomolecule analysis. This review explores the growing significance of mass spectrometry (MS), particularly when coupled with liquid chromatography (LC), in identifying disease biomarkers and quantifying biomolecules for diagnostic and prognostic purposes. The unique advantages of MS in accurately identifying and quantifying diverse molecules have positioned it as a cornerstone in personalized-medicine advancement. MS-based technologies have transformed precision medicine, enabling a comprehensive understanding of disease mechanisms and patient-specific treatment responses. LC-MS has shown exceptional utility in analyzing complex biological matrices, while high-resolution MS has expanded analytical capabilities, allowing the detection of low-abundance molecules and the elucidation of complex biological pathways. The integration of MS with other techniques, such as ion mobility spectrometry, has opened new avenues for biomarker discovery and validation. As we progress toward precision medicine, MS-based technologies will be crucial in addressing the challenges of individualized patient care, driving innovations in disease diagnosis, prognosis, and treatment strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Precision MedicineBiomarkersMass SpectrometryHumansChromatography, Liquid

Stichwörter der Autor:innen

biomarker discoveryclinical chemistryliquid chromatography–mass spectrometrypersonalized medicine

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Department of Molecular Medicine, Scripps Research, San Diego, CA 92037, USA.
  • Department of Bio-AI Convergence, Chungnam National University, Daejeon 34134, Republic of Korea.
  • Department of Convergent Bioscience and Informatics, Chungnam National University, 99 Daehak-ro, Yuseong-gu, Daejeon 34134, Republic of Korea.
  • Protein AI Design Institute, Chungnam National University, 99 Daehak-ro, Yuseong-gu, Daejeon 34134, Republic of Korea.
  • SCICS, 99 Daehak-ro, Yuseong-gu, Daejeon 34134, Republic of Korea.

ORCID-Profile: Ahrum Son, Woojin Kim, Jongham Park, Hyunsoo Kim

Förderung

  • National Research Foundation of Korea (NRF)
  • Korea Basic Science Institute (National research Facilities and Equipment Center)
  • by Institute of Information & communications Technology Planning & Evaluation (IITP)
  • Institute of Information and Communications Technology Planning and Evaluation (IITP)
  • Korean government (MSIT)

Zitieren

APA

Son, A., Kim, W., Park, J., Park, Y., Lee, W., Lee, S., & Kim, H. (2024). Mass Spectrometry Advancements and Applications for Biomarker Discovery, Diagnostic Innovations, and Personalized Medicine. International Journal of Molecular Sciences, 25(18), 9880. https://doi.org/10.3390/ijms25189880

Vancouver

Son A, Kim W, Park J, Park Y, Lee W, Lee S, et al. Mass Spectrometry Advancements and Applications for Biomarker Discovery, Diagnostic Innovations, and Personalized Medicine. International Journal of Molecular Sciences. 2024;25(18):9880. doi:10.3390/ijms25189880

BibTeX
@article{Son2024,
  author = {Son, Ahrum and Kim, Woojin and Park, Jongham and Park, Yongho and Lee, Wonseok and Lee, Sangwoon and Kim, Hyunsoo},
  title = {Mass Spectrometry Advancements and Applications for Biomarker Discovery, Diagnostic Innovations, and Personalized Medicine},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  volume = {25},
  number = {18},
  pages = {9880},
  doi = {10.3390/ijms25189880}
}
Kostenlos starten →